Literature DB >> 12890367

Rapid loss of both CD4+ and CD8+ T lymphocyte subsets during the acute phase of severe acute respiratory syndrome.

Taisheng Li1, Zhifeng Qiu, Yang Han, Zhong Wang, Hongwei Fan, Wei Lu, Jing Xie, Xiaojun Ma, Aixia Wang.   

Abstract

OBJECTIVE: To study the alteration of peripheral lymphocyte subsets in severe acute respiratory syndrome (SARS) patients and to help improve the early diagnosis of the disease.
METHODS: Anti-coagulating blood samples from 98 SARS patients in the acute phase, 56 normal healthy blood donors, and from patients infected by HIV, CMV and EBV were collected. The T lymphocyte subsets were counted by flow cytometry using fluorescence-labeled specific monoclonal antibodies.
RESULTS: A significant decrease was observed in all SARS patients in their peripheral CD4(+) and CD8(+) T lymphocyte absolute counts [256 (104) x 10(6)/L and 256 (117) x 10(6)/L, respectively], which were also lower than those of the patients infected with HIV, CMV and EBV. All patients infected with HIV, CMV and EBV had significantly higher CD8(+) T lymphocyte counts in comparison with normal controls.
CONCLUSIONS: Decrease of both CD4(+) and CD8(+) T lymphocytes of patients is related to onset of SARS. T lymphocyte subset analysis would help improve the early diagnosis of the disease.

Entities:  

Mesh:

Year:  2003        PMID: 12890367

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  23 in total

1.  7a protein of severe acute respiratory syndrome coronavirus inhibits cellular protein synthesis and activates p38 mitogen-activated protein kinase.

Authors:  Sarah A Kopecky-Bromberg; Luis Martinez-Sobrido; Peter Palese
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 2.  The Immune Responses against Coronavirus Infections: Friend or Foe?

Authors:  Arefe Vafaeinezhad; Mohammad Reza Atashzar; Rasoul Baharlou
Journal:  Int Arch Allergy Immunol       Date:  2021-05-05       Impact factor: 2.749

Review 3.  T cell-mediated immune response to respiratory coronaviruses.

Authors:  Rudragouda Channappanavar; Jincun Zhao; Stanley Perlman
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

4.  Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.

Authors:  Liang Xie; Qinhan Wu; Qunying Lin; Xuhui Liu; Weihua Lin; Shengyu Hao; Weiping Hu; Guiling Xiang; Hongzhou Lu; Shanqun Li
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

Review 5.  Hematological findings in coronavirus disease 2019: indications of progression of disease.

Authors:  Xiaoqing Liu; Run Zhang; Guangsheng He
Journal:  Ann Hematol       Date:  2020-06-03       Impact factor: 3.673

Review 6.  Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.

Authors:  Yanwen Liang; Mong-Lien Wang; Chian-Shiu Chien; Aliaksandr A Yarmishyn; Yi-Ping Yang; Wei-Yi Lai; Yung-Hung Luo; Yi-Tsung Lin; Yann-Jang Chen; Pei-Ching Chang; Shih-Hwa Chiou
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

7.  Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China.

Authors:  Ruchong Chen; Ling Sang; Mei Jiang; Zhaowei Yang; Nan Jia; Wanyi Fu; Jiaxing Xie; Weijie Guan; Wenhua Liang; Zhengyi Ni; Yu Hu; Lei Liu; Hong Shan; Chunliang Lei; Yixiang Peng; Li Wei; Yong Liu; Yahua Hu; Peng Peng; Jianming Wang; Jiyang Liu; Zhong Chen; Gang Li; Zhijian Zheng; Shaoqin Qiu; Jie Luo; Changjiang Ye; Shaoyong Zhu; Jinping Zheng; Nuofu Zhang; Yimin Li; Jianxing He; Jing Li; Shiyue Li; Nanshan Zhong
Journal:  J Allergy Clin Immunol       Date:  2020-05-11       Impact factor: 10.793

8.  Considerations in treating patients with advance lung cancer during the epidemic outbreak of novel coronavirus (SARS-CoV-2).

Authors:  Yangyang Cai; Yinghui Xu; Dongsheng Xu; Yizhuo Wang; Xu Wang; Chao Sun; Ye Guo; Shi Qiu; Kewei Ma
Journal:  Med Oncol       Date:  2020-08-03       Impact factor: 3.064

9.  Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19).

Authors:  Xiaotian Dong; Mengyan Wang; Shuangchun Liu; Jiaqi Zhu; Yanping Xu; Hongcui Cao; Lanjuan Li
Journal:  Aging Dis       Date:  2020-05-09       Impact factor: 6.745

10.  Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome.

Authors:  Liping Sun; Yanjie Hu; Aime Niyonsaba; Qiaoxia Tong; Li Lu; Huiyu Li; Shenghua Jie
Journal:  Clin Exp Med       Date:  2013-09-26       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.